Search Within

Steven M Larson

Formats
  1. Journal Article (544)
  2. Meeting Abstract (350)
  3. Book Section (29)
  4. Conference Paper (23)
  5. Editorial (5)
  6. Review (4)
  7. Book Whole (3)
  8. Miscellaneous (1)
Groups
  1. GSK Faculty (959)
  2. Molecular Imaging and Therapy Service (959)
  3. Molecular Pharmacology and Chemistry Program Faculty (959)
  4. Radiology, Department of (959)
  5. Sloan Kettering Institute Faculty (959)
  6. Department of Medicine (386)

More Groups

People
  1. John Humm (185)
  2. Ronald Finn (184)
  3. Pat Zanzonico (112)
  4. Howard Scher (110)
  5. Nai-Kong Cheung (108)
  6. Chaitanya Divgi (103)

More People

Years
  1. 2025 (6)
  2. 2024 (8)
  3. 2023 (11)
  4. 2022 (23)
  5. 2021 (14)
  6. 2020 (18)

More Years

Publications
  1. Journal of Nuclear Medicine (294)
  2. Journal of Clinical Oncology (84)
  3. Clinical Cancer Research (34)
  4. Cancer Research (29)
  5. European Journal of Nuclear Medicine (24)
  6. European Journal of Nuclear Medicine and Molecular Imaging (22)

More Publications

Publishers
  1. Society of Nuclear Medicine (294)
  2. American Society of Clinical Oncology (85)
  3. American Association for Cancer Research (83)
  4. Springer (77)
  5. Elsevier Inc. (49)
  6. Lippincott Williams & Wilkins (31)

More Publishers

Results (959)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacokinetic-based treatment planning for fractionated radioimmunotherapy of renal cell cancer with I-131-labeled monoclonal antibody CG250
    Meeting Abstract

    O'Donoghue, J. A.; Anwar, K.; Kavanagh, K. R.; Larson, S. M.; Old, L. J.; Divgi, C. R.
    Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • Optimizing combination therapy with radiolabeled antibodies and external beam
    Meeting Abstract

    Humm, J. L.; Ruan, S.; Larson, S. M.; O'Donoghue, J. A.
    Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • Parametric images of pharmacokinetics: Clinical implementation in Bi-213-HuM195 therapy of leukemia
    Meeting Abstract

    Kolbert, K. S.; Jurcic, J. G.; Larson, S. M.; Scheinberg, D. A.; Sgouros, G.
    Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • Comparative biodistribution of In-111 and Y-86 labeled humanized monoclonal antibody 3S193
    Meeting Abstract

    Lovqvist, A.; Humm, J. L.; Pentlow, K. S.; Finn, R. D.; Jungbluth, A.; Lee, F. T.; Scott, A. M.; Larson, S. M.
    Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • Comparison of F-18-FDG PET, I-131-MIBG, In-111-Pentetreotide, and Tc99m-MDP scintigraphy with conventional imaging modalities, for the detection of tumor lesions in patients with neuroblastoma
    Meeting Abstract

    Nunez, R. F.; Henry, H. W. D.; Macapinlac, H. A.; Yeh, S. D. J.; Akhurst, T.; Rini, J. N.; Weiping, W.; Larson, S. M.
    Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • Fractionated radioimmunotherapy with I-131-labeled chimeric antibody G250 (cG250) in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Divgi, C. R.; O'Donoghue, J. A.; McGagh, D. A.; Motzer, R. J.; Anwar, K.; Sheikh, A.; Gonzalez, R. S.; Welt, S.; Old, L. J.; Larson, S. M.
    Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • Fractionated radioimmunotherapy with I-131 chimeric antibody G250 (cG250) in metastatic renal cancer
    Meeting Abstract

    Divgi, C. R.; O'Donoghue, J. A.; McGagh, D.; Anwar, K.; Motzer, R.; Welt, S.; Larson, S. M.; Old, L. J.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • A comparison of reconstruction algorithms with FDG-PET: Iterative reconstruction segmented attenuation correction (IRSAC) allows greater lesion detectability than filtered back projection (FBP)
    Meeting Abstract

    Akhurst, T.; Erdi, Y.; Macapinlac, H.; Humm, J.; Yeung, H.; Larson, S. M.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • A comparison of reconstruction algorithms with FDG-PET: Iterative reconstruction segmented attenuation correction (IRSAC) allows greater lesion detectability than filtered back projection (FBP)
    Meeting Abstract

    Akhurst, T.; Erdi, Y.; Macapinlac, H.; Humm, J.; Yeung, H.; Larson, S. M.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • [F-18]2-fluoro-2-doxyglucose (FDG) and C-11-methionine (C-11 MET) positron emission tomography (PET) versus conventional imaging modalities (CIM) in patients with newly progressing metastatic prostate cancer
    Meeting Abstract

    Nunez, R.; Macapinlac, H.; Yeung, H. W. D.; Akhurst, T.; Finn, R. D.; Osman, I.; Petrisko, R.; Scher, H. I.; Larson, S. M.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save